These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34999607)

  • 1. Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    Isfordink CJ; Smit C; Boyd A; de Regt MJA; Rijnders BJA; van Crevel R; Ackens RP; Reiss P; Arends JE; van der Valk M;
    AIDS; 2022 May; 36(6):773-783. PubMed ID: 34999607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
    Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
    Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and Disparity.
    Falade-Nwulia O; Lesko CR; Fojo AT; Keruly JC; Moore RD; Sutcliffe CG; Mehta SH; Chander G; Thomas DL; Sulkowski M
    J Infect Dis; 2024 Mar; 229(3):775-779. PubMed ID: 37793170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
    Baumann L; Braun DL; Cavassini M; Stoeckle M; Bernasconi E; Schmid P; Calmy A; Haerry D; Béguelin C; Fux CA; Wandeler G; Surial B; Rauch A
    Liver Int; 2024 Jan; 44(1):169-179. PubMed ID: 37850685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
    Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
    Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands.
    Boerekamps A; Newsum AM; Smit C; Arends JE; Richter C; Reiss P; Rijnders BJA; Brinkman K; van der Valk M;
    Clin Infect Dis; 2018 Apr; 66(9):1352-1359. PubMed ID: 29186365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
    Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV
    Clin Infect Dis; 2020 Sep; 71(6):1502-1510. PubMed ID: 31585005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.
    Chromy D; Bauer DJM; Simbrunner B; Jachs M; Hartl L; Schwabl P; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Mandorfer M; Gschwantler M; Reiberger T
    J Viral Hepat; 2022 May; 29(5):385-394. PubMed ID: 35274399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C microelimination among people living with HIV in Taiwan.
    Chen GJ; Ho SY; Su LH; Chang SY; Hsieh SM; Sheng WH; Liu WD; Huang YS; Lin KY; Chen YT; Su YC; Liu WC; Sun HY; Hung CC
    Emerg Microbes Infect; 2022 Dec; 11(1):1664-1671. PubMed ID: 35608049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals.
    Popping S; Cuypers L; Claassen MAA; van den Berk GE; De Weggheleire A; Arends JE; Boerekamps A; Molenkamp R; Koopmans MPG; Verbon A; Boucher CAB; Rijnders B; van de Vijver DAMC
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
    Monin MB; Ingiliz P; Lutz T; Scholten S; Cordes C; Martínez-Rebollar M; Spinner CD; Nelson M; Rausch M; Bhagani S; Peters L; Reiberger T; Mauss S; Rockstroh JK; Boesecke C;
    Clin Infect Dis; 2023 Feb; 76(3):e607-e612. PubMed ID: 36004410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
    Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M;
    Lancet HIV; 2024 Feb; 11(2):e106-e116. PubMed ID: 38224708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure rates.
    Chromy D; Bauer D; Simbrunner B; Jachs M; Hartl L; Schwabl P; Binter T; Steininger L; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Peck-Radosavljevic M; Mandorfer M; Reiberger T
    Infect Dis (Lond); 2023 Mar; 55(3):189-198. PubMed ID: 36484317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects.
    Hlavay BA; Zhuo R; Ogando N; Charlton C; Stapleton JT; Klein MB; Power C
    J Clin Virol; 2023 May; 162():105445. PubMed ID: 37043902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.
    Requena MB; Protopopescu C; Stewart AC; van Santen DK; Klein MB; Jarrin I; Berenguer J; Wittkop L; Salmon D; Rauch A; Prins M; van der Valk M; Sacks-Davis R; Hellard ME; Carrieri P; Lacombe K;
    Int J Drug Policy; 2024 Feb; 124():104311. PubMed ID: 38184902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus infection among men who have sex with men with human immunodeficiency virus-1 infection between 2010 and 2020 in Japan: A single-center retrospective cohort study.
    Nishikawa K; Kimura M; Imamura J; Kimura K
    J Infect Chemother; 2023 Mar; 29(3):263-268. PubMed ID: 36585274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.
    Chen PH; Yenokyan K; Fojo AT; Hutton HE; Lesko CR; McCaul ME; Yang C; Cachay ER; Crane HM; Jacobson JM; Kim HN; Kitahata MM; Mayer KH; Moore RD; Napravnik S; Saag M; Lau B; Chander G
    Drug Alcohol Depend; 2022 Dec; 241():109673. PubMed ID: 36332596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
    Boerekamps A; van den Berk GE; Lauw FN; Leyten EM; van Kasteren ME; van Eeden A; Posthouwer D; Claassen MA; Dofferhoff AS; Verhagen DWM; Bierman WF; Lettinga KD; Kroon FP; Delsing CE; Groeneveld PH; Soetekouw R; Peters EJ; Hullegie SJ; Popping S; van de Vijver DAMC; Boucher CA; Arends JE; Rijnders BJ
    Clin Infect Dis; 2018 Apr; 66(9):1360-1365. PubMed ID: 29186320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.